Ibidi µ-Slide I 0.6 Luer ibiTreat 80186
The Ibidi µ-Slide I 0.6 Luer ibiTreat 80186 is a specialized cell culture slide designed for microscopy applications. It features a 0.6 Luer connector that allows for easy and secure connection to external devices such as syringes or tubing. The slide is made of biocompatible plastic and is treated with ibiTreat surface modification, promoting optimal cell adhesion and growth.
- Benefits/Advantages:
- Enhanced connectivity: The 0.6 Luer connector enables seamless connection to devices for precise sample manipulation or drug application, enhancing experimental versatility.
- Reliable cell adhesion: The ibiTreat surface treatment promotes consistent cell attachment and spreading, ensuring reliability and reproducibility in cell-based experiments.
- Compatibility: The slide is designed to fit standard microscopy equipment, allowing seamless integration into existing protocols and workflows.
- High optical quality: The transparent plastic material of the slide enables excellent optical clarity, providing optimal imaging conditions for microscopy.
Product Details
Model | |
---|---|
Product Type | Consumables |
Part Number | 80186 |
Brand | ibidi GmbH |
Gross Dimensions (WxDxH cm) | |
Net Dimensions (WxDxH cm) | |
Gross Weight (kg) | |
Net Weight (kg) |
Coverslip Material | Polymer Coverslip |
---|
ibidi GmbH
ibidi is a leading global supplier for functional cell-based assays and advanced products for cellular microscopy. A shared passion among the team for innovation, quality, service and a strong relationship to the customers, are the keys to ibidi's excellence and success.
ibidi is committed to supplying the highest quality products and service at a good value. Its innovative research tools enabling scientists to achieve outstanding success and breakthroughs in life sciences, pharma, biotechnology, and medical diagnostics. ibidi’s goal is to provide scientists with standardized workflows that result in reproducible and truly objective scientific data, which can also be translated into therapies.